Hormonal contraception

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase II: 2 Phase IV: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

2 trials
  • Mylan Inc. Commercial
    NORELGESTROMIN
    2025-522565-30-00 1 country 2025 n=60
    Recruiting
  • SocraTec R&D Concepts in Drug Research and Development GmbH Commercial
    LEVONORGESTREL
    2025-521236-12-00 1 country 2025 n=34
    Ended

Phase IV

1 trial
  • Region Uppsala Academic
    IMP not specified
    2023-507842-10-00 1 country 2024 n=60
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Mylan Inc. Commercial 1 Phase II 1
SocraTec R&D Concepts in Drug Research and Development GmbH Commercial 1 Phase II 0
Region Uppsala Academic 1 Phase IV 0
New trials by year
2024
1
2025
2
← All indication landscapes